VRPX — Virpax Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study
U.S. STOCKS ON THE MOVE-AMC, Alnylam, Super Micro
U.S. STOCKS ON THE MOVE-Replimune, Snowflake, Virpax Pharmaceuticals
U.S. STOCKS ON THE MOVE-Snowflake, GE Vernova, EQT Corp
Virpax Pharma declines after Nasdaq non-compliance notice
Brief: Virpax Pharmaceuticals Inc - On Nov 19, Received Nasdaq Non-Compliance Notice
Brief: Virpax Announces Positive Results For The Swine Model Dose Range Finding Study For Probudur™
Brief: Virpax Announces Agreement With U.S. Department Of Health And Human Services For Developmental Extension For NES100
Brief: Virpax Pharmaceuticals - Appointed Usama Chaudhry As CFO - SEC Filing
Brief: Virpax Pharmaceuticals Announces Closing Of $5.0 Million Public Offering Of Common Stock And Pre-Funded Warrants
Brief: Virpax Pharmaceuticals Got Staff Nasdaq Staff Determination Letter That Co Did Not Meet Terms Of Extension To Regain Compliance
Brief: Virpax Pharmaceuticals Inc Entered Into An Extension Agreement
Brief: Virpax Pharmaceuticals Says Eric Floyd Will Resign From Board, Effective Immediately
Virpax Pharma rises as pain medication shows promise in animal study
Virpax Pharma rises as pain medication shows promise in animal study
Brief: Virpax Announces Positive Results Of Swine Model Pilot Study For Probudur